The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.50
Bid: 272.00
Ask: 272.50
Change: 3.50 (1.30%)
Spread: 0.50 (0.184%)
Open: 272.00
High: 273.00
Low: 271.50
Prev. Close: 269.00
GRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Rights Issue

18 Dec 2018 07:00

RNS Number : 7534K
Grainger PLC
18 December 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

18 December 2018

Grainger plc (the "Company")

Results of Rights Issue

The Company today announces that the fully underwritten 7 for 15 Rights Issue of 194,758,491 New Ordinary Shares at 178.0 pence per New Ordinary Share announced on 14 November 2018 closed for acceptances at 11.00 am (London time) on 17 December 2018. The Company received valid acceptances in respect of 186,870,430 New Ordinary Shares, representing approximately 95.95 per cent. of the total number of New Ordinary Shares offered pursuant to the Rights Issue.

It is expected that the New Ordinary Shares will commence trading, fully paid, on the London Stock Exchange's main market for listed securities at 8.00 am today, 18 December 2018.

It is also expected that the New Ordinary Shares held in uncertificated form will be credited to CREST accounts as soon as practicable after 8.00 am today, 18 December 2018, and that definitive share certificates in respect of the New Ordinary Shares held in certificated form will be despatched by post by no later than 3 January 2019.

In accordance with their obligations under the Underwriting Agreement, J.P. Morgan Cazenove and Numis Securities Limited (the "Banks") will use reasonable endeavours to procure subscribers for the remaining 7,888,061 New Ordinary Shares not validly taken up in the Rights Issue, failing which the Banks have agreed to subscribe, on a several basis, for any remaining New Ordinary Shares.

The net proceeds (if any) from the placing of such New Ordinary Shares (after the deduction of the Rights Issue Price of 178.0 pence per New Ordinary Share and the expenses of procuring subscribers including any applicable brokerage and commissions and amounts in respect of VAT which are not recoverable) will be paid (without interest) to those persons whose rights have lapsed in accordance with the terms of the Rights Issue, pro rata to the entitlements not taken up, save that no payment will be made of amounts of less than £5.00 per holding, which amounts will be aggregated and ultimately accrue for the benefit of the Company.

A further announcement as to the number of New Ordinary Shares for which subscribers have been procured will be made in due course.

Capitalised terms used in this announcement have the meanings given to them in the combined prospectus and class 1 circular dated 14 November 2018 (the "Prospectus"), which is available on the Company's website (www.graingerplc.co.uk).

For further information, please contact:

Grainger plc

Helen Gordon, Chief Executive Officer

Vanessa Simms, Chief Financial Officer

Kurt Mueller, Director of Corporate Affairs

 

Telephone: +44 (0) 20 7940 9500

 

Camarco

Ginny Pulbrook

Geoffrey Pelham-Lane

Tom Huddart

 

Telephone: +44 (0) 203 757 4992

 

J.P. Morgan Cazenove (Lead Financial Adviser, Joint Bookrunner and Joint Broker to Grainger)

 

Bronson Albery

Barry Meyers

 

Telephone: +44 (0) 207 742 4000

 

Numis Securities Limited (Sponsor, Joint Bookrunner and Joint Broker to Grainger)

 

Heraclis Economides

Richard Thomas

Ben Stoop

 

Telephone: +44 (0)20 7260 1000

 

Kempen (Financial Adviser)

Dick Boer

Thomas ten Hoedt

 

Telephone: +31 20 348 8500

 

IMPORTANT NOTICE

The contents of this announcement have been prepared by and are the sole responsibility of Grainger.

This announcement is not a prospectus but an advertisement and investors should not acquire any securities referred to in this announcement except on the basis of the information contained in the Prospectus. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

Neither the content of Grainger's website nor any website accessible by hyperlinks on Grainger's website is incorporated in, or forms part of, this announcement.

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement, the Prospectus and the Provisional Allotment Letters should not be distributed, forwarded to or transmitted in or into in any jurisdiction where to do so might constitute a violation of local securities laws or regulations, including the United States, Australia, Canada, Japan and South Africa.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. This announcement does not constitute or form part of an offer of securities for sale or solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan, South Africa or in any other jurisdiction in which such offer may be restricted. The securities referred to in this announcement have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state in the United States and may not be offered or sold in the United States, except in reliance on an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will be no public offering of securities in the United States.

Each of J.P. Morgan Cazenove, which is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the Financial Conduct Authority (the "FCA") and the PRA, and Numis (together with J.P. Morgan Cazenove, the "Banks"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no one else in connection with the Acquisition and the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to clients of the Banks, nor for providing advice in relation to the Acquisition, the Rights Issue or any other matters referred to in this announcement. Neither the Banks nor any of their respective affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, tort or, under statute or otherwise) to any person who is not a client of the Banks in connection with this announcement, any statement contained in herein or otherwise.

Kempen & Co N.V. ("Kempen") which is authorised and regulated in the Netherlands by the Dutch Authority for Financial Markets (AFM) is acting exclusively for the Company and to no one else in connection with the Acquisition and will not be responsible to anyone other than the Company for providing advice in relation to the Acquisition. Kempen, nor any of its respective affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, tort or, under statute or otherwise) to any person in connection with this announcement, any statement contained in herein or otherwise.

This announcement does not constitute a recommendation concerning the Rights Issue. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIDMMMZMNKGRZZ
Date   Source Headline
9th May 202411:02 amRNSDirector/PDMR Shareholding
1st May 202411:57 amRNSTotal Voting Rights
29th Apr 20244:00 pmRNSBlock listing Interim Review
4th Apr 202412:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20247:00 amRNSNotice of Interim Results
7th Mar 20242:52 pmRNSTotal Voting Rights
7th Mar 202411:48 amRNSDirector/PDMR Shareholding
7th Feb 20243:11 pmRNSResult of AGM
7th Feb 20247:00 amRNSTrading Update
6th Feb 202410:09 amRNSDirector/PDMR Shareholding
1st Feb 20244:31 pmRNSTotal Voting Rights
9th Jan 202412:14 pmRNSDirector/PDMR Shareholding
12th Dec 202312:54 pmRNSTotal Voting Rights
12th Dec 202312:46 pmRNSDirector/PDMR Shareholding
12th Dec 202312:44 pmRNSDirector/PDMR Shareholding
6th Dec 20231:49 pmRNSDirector/PDMR Shareholding
22nd Nov 20237:01 amRNSNew BTR partnership with Network Rail & Bloc Group
22nd Nov 20237:00 amRNSFinal Results
6th Nov 20234:12 pmRNSDirector/PDMR Shareholding
6th Oct 20231:09 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSTrading Update
2nd Oct 202311:08 amRNSBlock listing Interim Review
21st Sep 20233:45 pmRNSTotal Voting Rights
7th Sep 20232:53 pmRNSDirector/PDMR Shareholding
8th Aug 20231:03 pmRNSDirector/PDMR Shareholding
25th Jul 20232:20 pmRNSDirector/PDMR Shareholding
5th Jul 202311:35 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Update and Capital Markets Event
7th Jun 20231:31 pmRNSDirector/PDMR Shareholding
25th May 20234:04 pmRNSEBT Purchase
19th May 20234:04 pmRNSEBT purchase
18th May 20237:00 amRNSStatement re Rent Reform Bill
11th May 20237:00 amRNSHalf year financial results
5th May 202312:44 pmRNSDirector/PDMR Shareholding
6th Apr 20232:02 pmRNSDirector/PDMR Shareholding
4th Apr 202310:25 amRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSNotice of Results
13th Mar 202311:57 amRNSTotal Voting Rights
7th Mar 202312:46 pmRNSDirector/PDMR Shareholding
15th Feb 20231:35 pmRNSDirector/PDMR Shareholding
8th Feb 20234:16 pmRNSResult of AGM
8th Feb 20237:00 amRNSTrading Update
7th Feb 202312:12 pmRNSDirector/PDMR Shareholding
7th Feb 202312:08 pmRNSDirector/PDMR Shareholding
6th Feb 20233:14 pmRNSTotal Voting Rights
20th Jan 20235:12 pmRNSAGM Statement
12th Jan 202312:16 pmRNSTotal Voting Rights
10th Jan 20232:33 pmRNSDirector/PDMR Shareholding
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.